Bacterial Aminopeptidase-Activated Peptide Prodrug Enables Species-Selective Targeting of Pseudomonas aeruginosa
Related Experiment Video
Updated: Aug 23, 2026

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
Published on: May 4, 2018
Qingtian Gong1, Silvia Synowsky2, Aisling Lynch3,4
1Biomolecular Sciences building, School of Biology, University of St Andrews, North HaughKY16 9ST, U.K.
Abstract:
Pseudomonas aeruginosa is an adaptable organism, frequently found in chronic infections, and for which antimicrobial resistance is a growing concern. Therefore, there is an urgent need for alternative therapeutic strategies. Cationic antimicrobial peptides (AMPs) offer potent bactericidal activity but suffer from limited selectivity and potential host toxicity. To enhance species-specific targeting, we designed two prodrug variants of the AMP D-Bac8CLeu2,5─EEEE-D-Bac8CLeu2,5 and ELEG-D-Bac8CLeu2,5─engineered for activation by the P. aeruginosa extracellular aminopeptidase PaAP. While both prodrug motifs effectively neutralized the positive charge of D-Bac8CLeu2,5 and prevented DNA-peptide complex formation, EEEE-D-Bac8CLeu2,5 showed negligible antimicrobial activity due to slow and incomplete activation. In contrast, ELEG-D-Bac8CLeu2,5 underwent rapid PaAP-mediated activation, restoring bactericidal activity in planktonic cultures and biofilms. PaAP contributed significantly to complete prodrug activation, particularly within biofilms, where the accumulation of partially activated intermediates correlated with biphasic killing kinetics. The prodrug showed reduced activity against other ESKAPEE pathogens, demonstrating selective activation by P. aeruginosa. Experiments selecting resistant bacteria revealed distinct mutations in lipopolysaccharide biosynthesis pathways for D-Bac8CLeu2,5 and the prodrug, with limited cross-resistance. These findings establish aminopeptidase-activated AMP prodrugs as a promising approach for species-selective antimicrobial therapy and highlight the feasibility of exploiting bacterial enzymes for controlled antimicrobial peptide activation.
Insights
New antimicrobial peptide prodrugs show promise for treating Pseudomonas aeruginosa infections. Engineered for activation by a specific bacterial enzyme, these prodrugs demonstrate targeted bacterial killing with reduced resistance potential.
Area of Science:
- Microbiology
- Biochemistry
- Drug Discovery
Background:
- Antimicrobial resistance in Pseudomonas aeruginosa necessitates novel therapeutic strategies.
- Cationic antimicrobial peptides (AMPs) are potent but lack selectivity and can cause host toxicity.
- Targeted activation of AMPs could overcome limitations and enhance efficacy.
Purpose of the Study:
- To design and evaluate AMP prodrugs activated by the Pseudomonas aeruginosa enzyme PaAP for species-specific antimicrobial therapy.
- To assess the activity of prodrugs against planktonic and biofilm forms of P. aeruginosa.
- To investigate the mechanisms of activation and resistance development.
Main Methods:
- Design and synthesis of two D-Bac8CLeu2,5 AMP prodrug variants (EEEE-D-Bac8CLeu2,5 and ELEG-D-Bac8CLeu2,5).
- In vitro testing of prodrug activation by purified PaAP and P. aeruginosa strains.
- Antimicrobial activity assays against planktonic cells and biofilms.
- Analysis of resistance development and cross-resistance patterns.
Main Results:
- The ELEG-D-Bac8CLeu2,5 prodrug demonstrated rapid and efficient activation by PaAP, restoring potent bactericidal activity.
- PaAP-mediated activation was crucial for killing P. aeruginosa in biofilms, influencing kinetics.
- The prodrug exhibited selective activity against P. aeruginosa with reduced efficacy against other ESKAPEE pathogens.
- Distinct resistance mutations emerged for the prodrug compared to the parent AMP, indicating limited cross-resistance.
Conclusions:
- Aminopeptidase-activated AMP prodrugs represent a viable strategy for species-selective antimicrobial therapy.
- Exploiting bacterial enzymes like PaAP enables controlled activation of AMPs.
- This approach offers a promising alternative for combating challenging P. aeruginosa infections and overcoming resistance.
More Related Videos
08:34Generation of In-Frame Gene Deletion Mutants in Pseudomonas aeruginosa and Testing for Virulence Attenuation in a Simple Mouse Model of Infection
Published on: January 8, 2020
09:45Production of Monoclonal Antibodies Targeting Aminopeptidase N in the Porcine Intestinal Mucosal Epithelium
Published on: May 18, 2021
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Bacterial Protein Synthesis